The jury in a California vaginal mesh lawsuit handed Johnson & Johnson, and their subsidiary, Ethicon, a $5.7 million verdict to be paid to the plaintiff for compensatory and punitive damages. After more than three days of deliberation, the jury agreed that Johnson & Johnson’s transvaginal mesh device, the Abbrevo, is defective.
Furthermore, the jury decided that Johnson & Johnson did not sufficiently educate health care providers and patients about the risks of using their Abbrevo vaginal mesh product.
The plaintiff in the case, Coleen Perry, received an implant of the Abbrevo device in 2011. According to Bloomberg, Perry experienced mesh erosion, and underwent further surgery to remove the Abbrevo device in 2012.
Johnson & Johnson has plans to appeal the verdict. An Ethicon spokesperson was quoted as saying, “Ethicon acted appropriately and responsibly” in handling all phases of bringing the Abbrevo transvaginal mesh device to market.
The defective medical device lawyers at Carey Danis & Lowe are pleased by the jury’s verdict, as it will bring much deserved relief and closure to Perry and her family.
Carey Danis & Lowe currently represents women who have been injured by transvaginal mesh products, including Ethicon’s Abbrevo sling. If you or someone you love has been injured by transvaginal mesh, we encourage you to explore your legal options and compensation eligibility with one of our attorneys today.
Carey Danis & Lowe offers free, no obligation case evaluations.
References: Defective Medical Device litigation, Transvaginal Mesh